Scientists at Uppsala University have discovered a new class of antibiotics with potent activity against multi-drug resistant bacteria, and have shown that it cures bloodstream infections in mice. The ...
A new experimental antibiotic can handily knock off one of the world’s most notoriously drug-resistant and deadly bacteria —in lab dishes and mice, at least. It does so with a never-before-seen method ...
Scientists in Switzerland have announced the discovery of a new class of antibiotics shown to be effective against deadly, drug-resistant bacteria. The antibiotic, called zosurabalpin, works by ...
A recent Nature journal study uses a deep learning approach to explore chemical sub-structures that helped discover structural classes of antibiotics. Study: Discovery of a structural class of ...
Hosted on MSN
New antibiotic is 100× stronger than current drugs
A new experimental antibiotic has stunned researchers by wiping out dangerous bacteria at concentrations roughly two orders of magnitude lower than some of the drugs doctors rely on today. Early lab ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Editor’s note: This article relays ...
Blujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial treatment option for drug-resistant urinary tract infections (UTIs). In clinical trials, ...
A groundbreaking antibiotic discovery might finally tip the balance in the global fight against drug-resistant bacteria. Scientists have unveiled a rare molecule with a fresh way to stop dangerous ...
Millions of women get UTIs each year. An antibiotic 30 years in the making is finally offering hope.
Add Yahoo as a preferred source to see more of our stories on Google. Blujepa, aka gepotidacin, is the first new class of antibiotics since the 1990s. (Photo illustration: Yahoo News; photo: Getty ...
But a new antibiotic from Swiss pharmaceutical company Roche could change the future of how we treat Gram-negative bacteria. Roche announced on Monday that its antibiotic zosurabalpin will enter phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results